In last trading session, Medtronic Plc (NYSE:MDT) saw 10.35 million shares changing hands with its beta currently measuring 0.81. Company’s recent per share price level of $87.00 trading at $1.4 or 1.64% at ring of the bell on the day assigns it a market valuation of $111.58B. That closing price of MDT’s stock is at a discount of -10.63% from its 52-week high price of $96.25 and is indicating a premium of 12.69% from its 52-week low price of $75.96.
For Medtronic Plc (MDT), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.24. Splitting up the data highlights that, out of 15 analysts covering the stock, 1 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 7 suggested the stock as a Hold whereas 7 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 1.23 in the current quarter.
Medtronic Plc (NYSE:MDT) trade information
Upright in the green during last session for gaining 1.64%, in the last five days MDT remained trading in the green while hitting it’s week-highest on Thursday, 06/05/25 when the stock touched $87.00 price level, adding 0.24% to its value on the day. Medtronic Plc’s shares saw a change of 8.91% in year-to-date performance and have moved 5.57% in past 5-day. Medtronic Plc (NYSE:MDT) showed a performance of 5.69% in past 30-days.
Wall Street analysts have assigned a consensus price target of 93 to the stock, which implies a rise of 6.45% to its current value. Analysts have been projecting 93 as a low price target for the stock while placing it at a high target of 93. It follows that stock’s current price would drop -6.9% in reaching the projected high whereas dropping to the targeted low would mean a loss of -6.9% for stock’s current value.
Medtronic Plc (MDT) estimates and forecasts
This year revenue growth is estimated to rise 5.16% from the last financial year’s standing.
25 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 8.37B for the same. And 25 analysts are in estimates of company making revenue of 8.74B in the next quarter. Company posted 7.92B and 8.4B of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 0.37% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 1.05% while estimates for its earnings growth in next 5 years are of 5.51%.
Medtronic Plc (NYSE:MDT)’s Major holders
VANGUARD GROUP INC is the top institutional holder at MDT for having 126.61 million shares of worth $9.97 billion. And as of 2024-06-30, it was holding 9.7895 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 111.89 million shares on 2024-06-30. The number of shares represents firm’s hold over 8.6517 of outstanding shares, having a total worth of $8.81 billion.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard 500 Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025, the former fund manager was holding 40.53 shares of worth $3.53 billion or 3.16% of the total outstanding shares. The later fund manager was in possession of 35.63 shares on Mar 31, 2025, making its stake of worth around $3.1 billion in the company or a holder of 2.78% of company’s stock.
